|
Press Releases |
|
|
|
Thursday, December 1, 2016 |
|
Luye Pharma Announces the Completion of Acquisition of Acino's Transdermal Drug Delivery Systems Business |
Luye Pharma Group Ltd. (2186.HK) is pleased to announce the completion of its acquisition of the transdermal drug delivery systems (TDS) business from Swiss company, Acino. The acquired business is a global leader in niche transdermal markets and will greatly enhance Luye's developmental efforts in R&D, more info >> |
|
Tuesday, July 26, 2016 |
|
綠葉製藥國際化邁出里程碑意義的一步 宣布簽約收購瑞士Acino公司之透皮釋藥業務 |
2016年7月25日,綠葉製藥集團有限公司(2186.HK)欣然宣布,與瑞士Acino公司簽約,以2.45億歐元購買旗下透皮釋藥業務,即Acino AG和Acino Supply AG(統稱“標的公司”)全部發行之股本。 more info >> |
|
绿叶制药国际化迈出里程碑意义的一步 宣布签约收购瑞士Acino公司之透皮释药业务 |
2016年7月25日,绿叶制药集团有限公司(2186.HK)欣然宣布,与瑞士Acino公司签约,以2.45亿欧元购买旗下透皮释药业务,即Acino AG和Acino Supply AG(统称“标的公司”)全部发行之股本。 more info >> |
|
Luye Pharma Takes a Milestone Step Forward; Proposed Acquisition of Acino's TDS Business |
Luye Pharma Group Ltd. (2186.HK) (the "Company", and together with its subsidiaries, "Luye Pharma" or the "Group") announces its agreement to acquire the TDS business from Acino, through the purchase of the entire issued share capital of Acino AG and Acino Supply AG (the "Target Group") for EUR245,000,000 (the "Acquisition"). more info >> |
|
Friday, May 6, 2016 |
|
Luye Medical welcomes Australia's Healthe Care to its Group |
Healthe Care, Australia's third largest private healthcare group, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund completed on April 18. more info >> |
|
Sunday, April 24, 2016 |
|
Singapore-based Luye Medical Group Completes Acquisition of Healthe Care, Australia's Third Largest Private Healthcare Group |
On April 18, 2016, Australia's third largest private healthcare group, Healthe Care, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund was completed. more info >> |
|
Friday, October 9, 2015 |
|
由綠葉製藥研發的我國首個創新藥獲批在美提交新藥申請 |
以研發為驅動,以國際化為目標的中國領先創新製藥企業--綠葉製藥集團(簡稱「公司」,連同其附屬公司,統稱「綠葉」,股份代號:2186.HK),近日宣佈,美國食品藥品監督管理局(FDA)確認公司研發的利培酮微球注射劑(LY03004)不需再進行任何臨床試驗,可在美提交新藥申請(NDA)。 more info >> |
|
China's First Innovative Drug Led by Luye Pharma Approved NDA in the U.S. |
The leading innovative pharmaceutical company with strong R&D capability and global vision in China market-Luye Pharma Group Ltd. (the "Company", together with its subsidiaries, "Luye", stock code: 2186.HK), announced that the United States Food and Drug Administration (the "FDA") has confirmed that no additional clinical trials are needed for the New Drug Application ("NDA") submission for Risperidone Extended-release Microspheres for Injection ("LY03004") in the U.S. more info >> |
|
Tuesday, June 2, 2015 |
|
綠葉製藥宣佈終止收購北京嘉林藥業股權之協議 |
以研發為驅動,以國際化為目標的中國領先創新製藥企業--綠葉製藥集團(股份代號:2186.HK)宣佈,終止收購北京嘉林藥業股份有限公司之股權協議。公司股票在短暫停牌後於今日恢復交易。 more info >> |
|
Thursday, May 14, 2015 |
|
綠葉製藥被納入MSCI中國指數 |
以研發為驅動,以國際化為目標的中國領先創新製藥企業--绿叶制药集团(股份代號:2186.HK)宣佈绿叶獲納入摩根士丹利資本國際(「MSCI」)環球標準指數系列中的中國指數成分股,將於今年5月29日收市後生效 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Formerra Achieves ISCC PLUS Certification Across U.S. Warehouses, Enhancing Sustainable Material Distribution
May 8, 2024 22:00 HKT/SGT
|
|
|
Build4Asia 及亞洲零售論壇暨博覽會今日開幕
May 8, 2024 21:29 HKT/SGT
|
|
|
Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study
May 8, 2024 21:10 HKT/SGT
|
|
|
Build4Asia and Retail Asia Conference & Expo Kick Off Today
May 8, 2024 21:10 HKT/SGT
|
|
|
国美金融科技宣布拟收购游戏公司CashBox Group
May 8, 2024 21:04 HKT/SGT
|
|
|
國美金融科技宣佈擬收購遊戲公司CashBox Group
May 8, 2024 21:00 HKT/SGT
|
|
|
Indonesian BFSI IT Summit: Revolutionizing Finance Through Digital Transformation
May 8, 2024 17:12 HKT/SGT
|
|
|
Crypto Oasis Thrives: UAE Blockchain Ecosystem sees Exponential Growth with 2,040 Active Organizations in Q1 2024
May 8, 2024 17:00 HKT/SGT
|
|
|
Datacloud APAC: Charting the Course for APAC's Cloud Future
May 8, 2024 16:20 HKT/SGT
|
|
|
アフリカがついに日本のビジネスにおける国境を開放
May 8, 2024 15:00: JST
|
|
|
以数智化殡葬直面变化与挑战 福寿园国际集团组团参加2024AFE亚洲殡仪及墓园博览暨会议
May 8, 2024 14:05 HKT/SGT
|
|
|
以數智化殯葬直面變化與挑戰 福壽園國際集團組團參加2024AFE亞洲殯儀及墓園博覽暨會議
May 8, 2024 14:01 HKT/SGT
|
|
|
Mitsubishi Heavy Industries Increases Dividends on Back of Historically High FY2023 Results, Releases FY2024 Guidance
May 8, 2024 14:27 JST
|
|
|
Capital.com 的客戶交易量在2023年超過了1萬億美元
May 8, 2024 12:18 HKT/SGT
|
|
|
Capital.com的客户交易量在2023年超过了1万亿美元
May 8, 2024 12:12 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|